Home › Funds › Redwood Grove Capital, LLC › ELAN
Redwood Grove Capital, LLC position in ELAN
ELANCO ANIMAL HEALTH INC · Health Care
Redwood Grove Capital, LLC reported holding 1,216,900 shares of ELAN (ELANCO ANIMAL HEALTH INC) in its Q3 2026 13F filing — a position valued at US$27.2M, representing 7.50% of its reported portfolio and ranking #2 among its reported holdings. Redwood Grove Capital, LLC has disclosed ELAN holdings in 7 of the last 7 reported quarters, going back to Q1 2025.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Redwood Grove Capital, LLC's ELAN position evolved
Redwood Grove Capital, LLC first disclosed a stake in ELAN in Q1 2025 at 860,000 shares (US$9.0M). The position peaked in Q2 2026 at 1,525,300 shares, worth US$37.5M. Across 7 filings, Redwood Grove Capital, LLC increased the stake 4 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,216,900 shares valued at US$27.2M — a reduction of -308,400 shares quarter over quarter.. Notable position changes include a 52% increase in Q2 2025 (shares rose 41% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2025 | 860.00K | $9.03M | New |
| Q2 2025 | 1.31M | $18.71M | Add |
| Q3 2025 | 1.41M | $28.34M | Add |
| Q4 2025 | 1.56M | $35.23M | Add |
| Q1 2026 | 1.29M | $30.91M | Reduce |
| Q2 2026 | 1.53M | $37.54M | Add |
| Q3 2026 | 1.22M | $27.25M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ELAN and 13F data
ELAN (ELANCO ANIMAL HEALTH INC) is a Health Care company. 30 other funds we track also report a position in ELAN — the largest reported positions include Dodge & Cox (US$1.66B), PRIMECAP MANAGEMENT CO/CA/ (US$1.02B), T. Rowe Price Investment Management, Inc. (US$707.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ELAN
- Dodge & Cox 67.40M sh · $1.66B · Q2 2026
- PRIMECAP MANAGEMENT CO/CA/ 45.44M sh · $1.02B · Q3 2026
- T. Rowe Price Investment Management, Inc. 28.75M sh · $707.56M · Q2 2026
- Black Creek Investment Management Inc. 13.39M sh · $299.86M · Q3 2026
- Marshall Wace 10.02M sh · $224.39M · Q3 2026
- JUPITER ASSET MANAGEMENT LTD 5.07M sh · $113.51M · Q3 2026
- Artemis Investment Management LLP 4.61M sh · $103.26M · Q3 2026
- BOWEN HANES & CO INC 3.45M sh · $77.14M · Q3 2026
- ExodusPoint Capital Management, LP 3.11M sh · $69.68M · Q3 2026
More on Redwood Grove Capital, LLC
FAQ
How long has Redwood Grove Capital, LLC held ELAN?
Redwood Grove Capital, LLC has disclosed ELAN holdings in 7 of the last 7 reported quarters, going back to Q1 2025.
What is Redwood Grove Capital, LLC's current position in ELAN?
As of Q3 2026, Redwood Grove Capital, LLC holds 1.22M shares of ELAN (ELANCO ANIMAL HEALTH INC), valued at $27.25M, representing 7.50% of its reported portfolio and ranking #2.
Has Redwood Grove Capital, LLC been buying or selling ELAN?
In the latest 13F filing (Q3 2026), Redwood Grove Capital, LLC reduced its position in ELAN. The position peaked in Q2 2026 at 1.53M shares.
Which other funds hold ELAN?
Other major institutional holders of ELAN include Dodge & Cox, PRIMECAP MANAGEMENT CO/CA/, T. Rowe Price Investment Management, Inc., among 30 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.